Finance

Lists
CU6:ASX
Clarity Pharmaceuticals Ltd
A$2.27
-0.44%
(-0.0100) 1D
Sep 7, 4:10:13 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for CU6...
Open
A$2.27
High
A$2.40
Low
A$2.24
Mkt. cap
846.89M
Avg. vol.
2.16M
Volume
2.66M
52-wk high
A$5.87
52-wk low
A$1.80
EPS
-A$0.29
Shares outstanding
373.08M
No. of employees
100
Open
A$2.27
High
A$2.40
Low
A$2.24
Mkt. cap
846.89M
Avg. vol.
2.16M
Volume
2.66M
52-wk high
A$5.87
52-wk low
A$1.80
EPS
-A$0.29
Shares outstanding
373.08M
No. of employees
100
About Clarity Pharmaceuticals Ltd
CEO-
Employees100
Founded2010
Headquarters-
SectorPharmaceutical industry
Websiteclaritypharmaceuticals.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.90M
2.90M
2.36M
2.36M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
25.25M
25.25M
20.29M
20.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.98M
5.98M
7.94M
7.94M
Operating expense
31.23M
31.23M
28.22M
28.22M
Total operating expenses
31.23M
31.23M
28.22M
28.22M
Operating income
-28.33M
-28.33M
-25.86M
-25.86M
Other non operating income
-
-
-
-
EBT including unusual items
-27.59M
-27.59M
-25.55M
-25.55M
EBT excluding unusual items
-27.59M
-27.59M
-25.55M
-25.55M
Income tax expense
176.20K
176.20K
254.08K
254.08K
Effective tax rate
-0.64%
-0.64%
-0.99%
-0.99%
Other operating expenses
-
-
-
-
Net income
-27.82M
-27.82M
-25.80M
-25.80M
Net profit margin
-958.28%
-958.28%
-1,093.21%
-1,093.21%
Earnings per share
-
-
-
-
Interest and investment income
2.12M
2.12M
1.89M
1.89M
Interest expense
-
-
-
-
Net interest expenses
2.12M
2.12M
1.89M
1.89M
Depreciation and amortization charges
-
-
-
-
EBITDA
-28.25M
-28.25M
-25.80M
-25.80M
Gain or loss from assets sale
-
-
5.12K
5.12K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps